Radar Telegram alerts Open Radar

FAS ordered the pharmaceutical manufacturer Grotex to pay 2 billion rubles for violation of competition.

תרגם לעברית

Раньше всех. Ну почти. · · Source

🇷🇺 Russia · Map

FAS ordered the pharmaceutical manufacturer Grotex to pay 2 billion rubles for violation of competition.

According to Kommersant, the Antimonopoly Service issued a parallel order to the company operating under the Solofram brand due to the launch of the generic Emporix for the treatment of diabetes on the market.

The rights to its active ingredient (empagliflozin) in Russia until 2030 belong to the German pharmaceutical company Boehringer Ingelheim.

More on Radar

Want to see every report in real time?

Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.

Sign up free
Share on WhatsApp Get alerts on Telegram